Clinical Trial Update: The Cheeky Study: A Novel Delivery System for CAB-RPV LA [NA]

View source ↗

Summary

Clinical trial update for The Cheeky Study evaluating a novel delivery system for CAB-RPV LA; status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CAB-RPV LA (cabotegravir long-acting and rilpivirine long-acting)

Snippet

Sponsor: Public Health Foundation Enterprises, Inc. | Conditions: HIV Infections | NA | Status: ACTIVE_NOT_RECRUITING